Genalyte Revenue and Competitors
Estimated Revenue & Valuation
- Genalyte's estimated annual revenue is currently $12.3M per year.
- Genalyte received $36.0M in venture funding in November 2016.
- Genalyte's estimated revenue per employee is $140,000
- Genalyte's total funding is $141.8M.
Employee Data
- Genalyte has 88 Employees.
- Genalyte grew their employee count by -15% last year.
Genalyte's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CMO | Reveal Email/Phone |
4 | SVP Product and Operations | Reveal Email/Phone |
5 | VP, Product Marketing | Reveal Email/Phone |
6 | General Counsel and Corporate Secretary | Reveal Email/Phone |
7 | Sr. Director Engineering | Reveal Email/Phone |
8 | Associate Director, IVD Manufacturing | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
Genalyte Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.5M | 132 | 8% | $1.4B | N/A |
What Is Genalyte?
In an age when information can be transmitted at the speed of light, physicians and patients should be able to expect reliable bloodwork results within minutes of a test being completed. Leaving a patient in limbo waiting days for results while test samples are shipped across the country is an unacceptable standard in the 21st century. Rapid test results that allow physicians to confidently make data-driven treatment decisions during a patient's office visit should become the new standard of care. Genalyte's vision is to transform the doctor-patient relationship by bringing the doctor, the patient, and the lab together to provide results when they matter: Now. Genalyte's platform is being designed with the goal of providing test results from a whole blood sample within fifteen minutes in the physician's office. Providing diagnostic results at the time and place they are needed when the patient is sitting in front of the doctor has the potential to empower physicians, improve quality of care for patients, and reduce resource utilization across the healthcare system. Genalyte's technology is based on a proprietary silicon biosensor design that is currently in use by pharmaceutical companies, contract research organizations and academic researchers. For more information, visit www.genalyte.com.
keywords:Biotechnology,Healthcare,Healthcare Providers,Medical Diagnostics,Pharmaceuticals$141.8M
Total Funding
88
Number of Employees
$12.3M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Genalyte News
San Diego-based Genalyte, a developer of laboratory diagnostics and analytics products, announced on Monday that it has raised $50M in a funding round. The funding was led by Verily, an Alphabet company, and also included Provenio Capital, Redmile, Khosla Ventures, HBM Partners, Samsara and othe ...
SAN DIEGO, Jan. 11, 2021 /PRNewswire/ -- Genalyte, a leading diagnostics and analytics company, announced today the closure of $50 million in financing. Genalyte's Maverick™ Diagnostic System (MDS) uses silicon chip based photonic ring resonance technology to perform multiple, simultaneous, ra ...
SAN DIEGO, Oct. 15, 2020 /PRNewswire/ -- Genalyte, a leading point-of-care diagnostics and analytics company, announced today its SARS-CoV-2 Multi-Antigen Serology Panel has received Emergency Use Authorization (EUA) from the FDA. The panel tests for the detection of IgG and IgM antibodies the ...
BaseHealth, a predictive, evidence-based, and data-driven population health management solution that targets the unknown risk by identifying the “Invisible Patients” has raised $8.5 million in Series C funding led by HBM Healthcare Investments. The Sunnyvale, CA-based digital health startup plan ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 88 | 11% | N/A |
#2 | $12.8M | 88 | 11% | N/A |
#3 | $22.1M | 88 | 29% | N/A |
#4 | $13.6M | 88 | 7% | $14.3M |
#5 | $12.9M | 88 | 0% | $194.5M |
Genalyte Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-08-19 | $44.0M | C | Khosla Ventures | Article |
2016-11-22 | $36.0M | Undisclosed | Khosla Ventures | Article |